HomeCompareRSASF vs JNJ

RSASF vs JNJ: Dividend Comparison 2026

RSASF yields 740.74% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RSASF wins by $1453571.23M in total portfolio value
10 years
RSASF
RSASF
● Live price
740.74%
Share price
$0.27
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1453571.26M
Annual income
$1,148,554,802,375.62
Full RSASF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — RSASF vs JNJ

📍 RSASF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRSASFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RSASF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RSASF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RSASF
Annual income on $10K today (after 15% tax)
$62,962.96/yr
After 10yr DRIP, annual income (after tax)
$976,271,582,019.28/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, RSASF beats the other by $976,271,578,033.29/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RSASF + JNJ for your $10,000?

RSASF: 50%JNJ: 50%
100% JNJ50/50100% RSASF
Portfolio after 10yr
$726785.64M
Annual income
$574,277,403,532.51/yr
Blended yield
79.02%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

RSASF
No analyst data
Altman Z
-796.7
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RSASF buys
0
JNJ buys
0
No recent congressional trades found for RSASF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRSASFJNJ
Forward yield740.74%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$1453571.26M$30.3K
Annual income after 10y$1,148,554,802,375.62$4,689.40
Total dividends collected$1429127.51M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RSASF vs JNJ ($10,000, DRIP)

YearRSASF PortfolioRSASF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$84,774$74,074.07$10,592$272.30+$74.2KRSASF
2$677,583$586,874.86$11,289$357.73+$666.3KRSASF
3$5,108,920$4,383,906.23$12,123$472.89+$5.10MRSASF
4$36,358,402$30,891,856.97$13,141$629.86+$36.35MRSASF
5$244,367,567$205,464,077.51$14,408$846.81+$244.35MRSASF
6$1,552,071,061$1,290,597,763.76$16,021$1,151.60+$1552.06MRSASF
7$9,321,534,421$7,660,818,385.65$18,122$1,588.22+$9321.52MRSASF
8$52,973,917,047$42,999,875,217.43$20,930$2,228.20+$52973.90MRSASF
9$285,062,106,249$228,380,015,007.86$24,792$3,191.91+$285062.08MRSASF
10$1,453,571,256,062$1,148,554,802,375.62$30,274$4,689.40+$1453571.23MRSASF

RSASF vs JNJ: Complete Analysis 2026

RSASFStock

RESAAS Services Inc. engages in the development of web and mobile communications software for the real estate industry. The company offers a suite of tools, which integrate with the platform, including a global referral network, lead generation engine, listing management, client engagement modules, customer relationship management tools, analytics, file sharing, payment system, and advertising engine. Its solutions include RealTimeMLS, a real-time listing solution and communication platform designed for real estate associations and multiple listing services (MLSs); and BrokerOS, an online communication hub that ensures agents open, read, and respond to the emails and messages sent to them by users. It serves MLSs, franchises, and real estate brokerage and real estate agents in the real estate industry. The company was incorporated in 2009 and is based in Vancouver, Canada.

Full RSASF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this RSASF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RSASF vs SCHDRSASF vs JEPIRSASF vs ORSASF vs KORSASF vs MAINRSASF vs ABBVRSASF vs MRKRSASF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.